- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SRO: SEROTONIN(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 37 residues within 4Å:- Chain A: V.7, G.8, G.9, G.10, F.11, S.12, L.30, E.31, G.32, G.37, G.38, R.39, A.40, G.56, G.57, A.58, Y.59, T.224, V.225, V.226, A.254, T.255, P.256, T.259, K.287, W.361, L.366, F.367, P.370, W.371, G.397, S.398, G.406, Y.407, I.408, A.411
- Ligands: SRO.1
37 PLIP interactions:37 interactions with chain A- Hydrophobic interactions: A:R.39, A:K.287, A:P.370, A:W.371
- Hydrogen bonds: A:G.9, A:G.10, A:S.12, A:G.32, A:R.39, A:A.40, A:G.57, A:A.58, A:Y.59, A:Y.59, A:V.226, A:V.226, A:S.398, A:S.398, A:G.406, A:I.408
- Water bridges: A:F.11, A:F.11, A:G.13, A:E.31, A:E.31, A:G.38, A:R.39, A:R.39, A:R.39, A:T.255, A:T.255, A:T.259, A:T.259, A:E.409
- Salt bridges: A:R.39, A:R.39
- pi-Stacking: A:W.371
FAD.5: 37 residues within 4Å:- Chain B: V.7, G.8, G.9, G.10, F.11, S.12, L.30, E.31, G.32, G.37, G.38, R.39, A.40, G.56, G.57, A.58, Y.59, T.224, V.225, V.226, A.254, T.255, P.256, T.259, K.287, W.361, L.366, F.367, P.370, W.371, G.397, S.398, G.406, Y.407, I.408, A.411
- Ligands: SRO.4
34 PLIP interactions:34 interactions with chain B- Hydrophobic interactions: B:R.39, B:K.287, B:P.370, B:W.371
- Hydrogen bonds: B:G.9, B:G.10, B:S.12, B:G.32, B:R.39, B:A.40, B:G.57, B:A.58, B:Y.59, B:Y.59, B:V.226, B:V.226, B:T.259, B:S.398, B:S.398, B:G.406, B:I.408
- Water bridges: B:F.11, B:F.11, B:G.13, B:E.31, B:E.31, B:G.38, B:R.39, B:R.39, B:R.39, B:E.409
- Salt bridges: B:R.39, B:R.39
- pi-Stacking: B:W.371
- 2 x GP7: (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(pentadecanoyloxy)methyl]ethyl (12E)-hexadeca-9,12-dienoate(Non-covalent)
GP7.3: 19 residues within 4Å:- Chain A: Q.99, A.100, F.101, V.111, T.115, F.159, L.160, W.163, M.180, I.191, L.192, V.195
- Chain B: F.101, I.103, P.104, G.105, S.106, A.108, V.111
14 PLIP interactions:6 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:F.101, B:A.108, B:V.111, A:F.101, A:F.101, A:V.111, A:F.159, A:L.160, A:W.163, A:I.191, A:V.195
- Hydrogen bonds: B:G.105, B:S.106
- Water bridges: B:S.106
GP7.6: 19 residues within 4Å:- Chain A: F.101, I.103, P.104, G.105, S.106, A.108, V.111
- Chain B: Q.99, A.100, F.101, V.111, T.115, F.159, L.160, W.163, M.180, I.191, L.192, V.195
14 PLIP interactions:6 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:F.101, A:A.108, A:V.111, B:F.101, B:F.101, B:V.111, B:F.159, B:L.160, B:W.163, B:I.191, B:V.195
- Hydrogen bonds: A:G.105, A:S.106
- Water bridges: A:S.106
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kachalova, G.S. et al., Crystal structure analysis of free and substrate-bound 6-hydroxy-L-nicotine oxidase from Arthrobacter nicotinovorans. J.Mol.Biol. (2010)
- Release Date
- 2011-03-23
- Peptides
- 6-hydroxy-L-nicotine oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
XB
X
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x SRO: SEROTONIN(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x GP7: (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(pentadecanoyloxy)methyl]ethyl (12E)-hexadeca-9,12-dienoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kachalova, G.S. et al., Crystal structure analysis of free and substrate-bound 6-hydroxy-L-nicotine oxidase from Arthrobacter nicotinovorans. J.Mol.Biol. (2010)
- Release Date
- 2011-03-23
- Peptides
- 6-hydroxy-L-nicotine oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
XB
X